IMP
Process View
negative regulation of natural killer cell mediated immunity
Any process that stops, prevents, or reduces the frequency, rate, or extent of natural killer cell mediated immunity.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of natural killer cell mediated immunity"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| HLA-A | major histocompatibility complex, class I, A | 0.902 | ||
| B2M | beta-2-microglobulin | 0.869 | ||
| HLA-B | major histocompatibility complex, class I, B | 0.801 | ||
| HLA-E | major histocompatibility complex, class I, E | 0.361 | ||
| HLA-F | major histocompatibility complex, class I, F | 0.283 | Human | |
| HLA-G | major histocompatibility complex, class I, G | 0.041 | Human | |
| HLA-C | major histocompatibility complex, class I, C | 0.039 | Human | |
| TAPBP | TAP binding protein (tapasin) | 0.030 | ||
| TAP1 | transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) | 0.021 | Rat | |
| LILRA6 | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 6 | 0.016 | ||
| TAP2 | transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) | 0.014 | Rat | |
| PILRA | paired immunoglobin-like type 2 receptor alpha | 0.013 | ||
| LILRB1 | leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1 | 0.011 |